G. N. Hortobagyi - Concepedia

Author

G. N. Hortobagyi

The University of Texas MD Anderson Cancer Center

Also Known As

G Hortobagyi, G N Hortobagyi, G. Hortobagyi, G. N. HORTOBAGYI, G. N. Hortobagyi, G.N. Hortobagyi, GN Hortobagyi, GN. Hortobagyi, Gabriel N. Hortobagyi, Hortobagyi

194

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Breast Cancer Care Sarah Cannon

About

G. N. Hortobagyi is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	30	1.1K
2	Health Sciences	12	12	461
3	Public Health	3	3	44
4	Natural Sciences	1	1	146
5	Biomolecular Engineering	1	1	146

G. N. Hortobagyi

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. G. N. Hortobagyi, Richard L. Theriault, A. Lipton, Journal of Clinical Oncology	1998	631
Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Juan Herrada, Revathy B. Iyer, E. Neely Atkinson, PubMed Breast OncologyNeoadjuvant ChemotherapyCancer DetectionMedicineMetronomic Therapy	1997	172
DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight Daniel J. Weisenberger, Binh N. Trinh, Mihaela Campan, Nucleic Acids Research Epigenetic ChangeGeneticsDna MethylationDna AnalysisMolecular Biology	2008	146
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2 Hope S. Rugo, Kathleen I. Pritchard, Michael Gnant, Annals of Oncology	2014	126
Update on endocrine therapy for breast cancer. Aman U. Buzdar, G. N. Hortobagyi PubMed Endocrine OncologyBreast OncologyMedicineEndocrine TherapiesPharmacology	1998	91
Safety and Efficacy of Bisphosphonates Beyond 24 Months in Cancer Patients Suhail M. Ali, Francisco J. Esteva, G. N. Hortobagyi, Journal of Clinical Oncology	2001	90
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. HM Kuerer, Newman La, Buzdar Au, PubMed	1998	68
Current management of advanced breast cancer. G. N. Hortobagyi, M. Piccart-Gebhart PubMed Surgical OncologyBreast OncologyMedicineCancer ManagementCurrent Management	1996	65
Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer. Yap Hy, Blumenschein Gr, MJ Keating, PubMed Breast OncologyVinca AlkaloidsMedicineContinuous 5-Day InfusionCancer Management	1980	64
Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer. H. Y. Yap, Philip A. Salem, G. N. Hortobagyi, PubMed Metastatic Breast CancerBreast OncologyMedicineContinuous 5-Day InfusionPharmacology	1978	61

Page 1